TrialHuman psychopharmacology2014

A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine.

Stuart A Montgomery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.